Rankings
▼
Calendar
XERS (Xeris Biopharma Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena
XERS
Xeris Biopharma Holdings, Inc.
Mkt Cap
$960M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$292M
Net Income (TTM)
$554,000
EPS (TTM)
-$0.01
Free Cash Flow (TTM)
$38M
Gross Margin
81.7%
Op. Margin
8.5%
Net Margin
0.2%
FCF Margin
12.9%
P/S Ratio (TTM)
3.3x
P/E Ratio (TTM)
1732.6x
YoY Rev Growth
+43.7%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$33M
$28M
-$13M
Q2 23
$38M
$30M
-$16M
Q3 23
$48M
$40M
-$5M
Q4 23
$44M
$34M
-$10M
Q1 24
$41M
$35M
-$14M
Q2 24
$48M
$38M
-$8M
Q3 24
$54M
$41M
-$13M
Q4 24
$60M
$51M
$2M
Q1 25
$60M
$51M
-$3M
Q2 25
$72M
$57M
$4M
Q3 25
$74M
$63M
$7M
Q4 25
$86M
$67M
$17M
marketcaparena.com
Revenue Breakdown
XERS
Xeris Biopharma Holdings, Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
7.9x
—
Q2 23
7.2x
—
Q3 23
6.3x
—
Q4 23
5.9x
—
Q1 24
5.6x
—
Q2 24
5.3x
—
Q3 24
5.1x
—
Q4 24
4.7x
—
Q1 25
4.3x
—
Q2 25
3.9x
—
Q3 25
3.6x
—
Q4 25
3.3x
1732.6x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$26M
-$26M
Q2 23
-$14M
-$15M
Q3 23
-$15M
-$15M
Q4 23
$6M
$6M
Q1 24
-$20M
-$20M
Q2 24
-$10M
-$11M
Q3 24
-$8M
-$8M
Q4 24
$2M
$2M
Q1 25
-$10M
-$10M
Q2 25
$182K
$10M
Q3 25
$18M
$18M
Q4 25
$20M
$20M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$238K
Q2 23
$2M
Q3 23
$345K
Q4 23
$132K
Q1 24
$164K
Q2 24
$397K
Q3 24
$87K
Q4 24
$220K
Q1 25
$13K
Q2 25
$13K
Q3 25
$363K
Q4 25
$333K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+50.4%
-9.1%
Q2 23
+50.2%
+22.1%
Q3 23
+62.6%
+9.7%
Q4 23
+33.9%
+12.2%
Q1 24
+22.4%
+18.1%
Q2 24
+26.5%
+4.2%
Q3 24
+12.3%
+26.2%
Q4 24
+35.4%
+7.7%
Q1 25
+47.9%
+15.2%
Q2 25
+48.8%
+19.2%
Q3 25
+37.1%
+0.7%
Q4 25
+42.8%
+18.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
7.7%
Q2 23
$3M
7.7%
Q3 23
$2M
5.1%
Q4 23
$3M
6.2%
Q1 24
$4M
9.3%
Q2 24
$4M
8.8%
Q3 24
$7M
12.5%
Q4 24
$4M
6.0%
Q1 25
$4M
7.4%
Q2 25
$5M
7.0%
Q3 25
$8M
10.3%
Q4 25
$5M
6.1%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$5M
$34M
Q2 23
$6M
$38M
Q3 23
$5M
$37M
Q4 23
$6M
$38M
Q1 24
$8M
$38M
Q2 24
$6M
$40M
Q3 24
$6M
$45M
Q4 24
$6M
$40M
Q1 25
$8M
$44M
Q2 25
$8M
$44M
Q3 25
$7M
$46M
Q4 25
$8M
$48M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$51M
$44M
$95M
Q2 23
$46M
$34M
$81M
Q3 23
$46M
$20M
$66M
Q4 23
$67M
$5M
$72M
Q1 24
$63M
$25M
$87M
Q2 24
$58M
$20M
$78M
Q3 24
$59M
$10M
$69M
Q4 24
$72M
$0
$72M
Q1 25
$58M
$0
$58M
Q2 25
$59M
$0
$59M
Q3 25
$92M
$0
$92M
Q4 25
$111M
$0
$111M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
137M
+0.9%
Q2 23
137M
+0.1%
Q3 23
138M
+0.5%
Q4 23
138M
+0.0%
Q1 24
141M
+1.7%
Q2 24
148M
+5.6%
Q3 24
149M
+0.4%
Q4 24
149M
+0.1%
Q1 25
152M
+2.2%
Q2 25
156M
+2.3%
Q3 25
178M
+13.9%
Q4 25
180M
+1.4%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 16
—
—
FY 17
—
—
FY 18
—
—
FY 19
—
—
FY 20
—
—
FY 21
$169K
294
FY 22
$311K
355
FY 23
$435K
377
FY 24
$515K
394
FY 25
$671K
435
marketcaparena.com